# Texture-audit Side-by-Side Comparison

Per Amendment 4 caveat: 3 retry instances (JSON-mode) vs 5 original-sample (seed=99).


## RETRY (JSON-mode)

### h3-F4-p2_cfo-stage_a_series_b_growth_burning-001
docs=6 total_chars=5638

**DOC 1: DOC 1 — Q3 P&L and Burn Summary (Finance)** (843c)

**Q3 FY24 Actuals vs. Plan**

| Metric | Q3 Actual | Q3 Plan | Var |
|---|---|---|---|
| New ARR | $1.42M | $1.95M | -27% |
| Expansion ARR | $610K | $720K | -15% |
| Gross Churn ARR | $480K | $310K | +55% |
| Net New ARR | $1.55M | $2.36M | -34% |
| Revenue (GAAP) | $3.71M | $3.82M | -3% |
| Gross Margin | 71% | 74% | -300bps |
| Opex | $7.62M | $7.45M | +2% |
| Net Burn | $3.98M | $3.21M | +24% |

**Burn multiple (Q3): 2.57x** (Net Burn / Net New ARR) — vs. 1.36x plan, 1.8x benchmark for Series B SaaS.

Cash on hand 9/30: $18.4M. At trailing 3-mo burn pace ($1.33M/mo), runway = 13.8 months. ...

**DOC 2: DOC 2 — Pipeline & Sales Capacity Review (VP Sales)** (906c)

**Pipeline snapshot — Oct 14**

Q4 committed pipeline: $4.1M (coverage 2.3x of $1.78M quota). Best-case: $5.6M. Historical Q4 close rate from this stage: 31%.

**Notable risks:**
- Three deals >$250K ACV slipped from Q3 to Q4 — all citing 'budget review' or 'evaluating Clarivue' (competitor).
- Mid-market segment (sub-$100K ACV) showing 18% lift in win rate after pricing tweak; enterprise stuck at 22%.
- Two top reps (combined $1.4M quota) actively interviewing per skip-level reports. One has competing offer from Rippling.

**Capacity:** 11 quota-carrying AEs. Ramped: 7. We hired 4 in Q2 expec...


---

### h3-F4-p2_cfo-stage_b_post_profitable_consolidation-001
docs=6 total_chars=5454

**DOC 1: DOC 1 — Q3 P&L and ARR Bridge (Finance Close Memo)** (835c)

**Q3 FY25 Close Summary — prepared by VP Finance**

- Ending ARR: $62.4M (+1.9% QoQ, +28% YoY)
- New ARR booked: $4.1M (vs $5.6M plan, $4.9M Q2)
- Gross churn: $2.3M (3.7% of starting ARR; trailing avg 2.9%)
- Net Revenue Retention: 108% (down from 114% in Q2, 121% a year ago)
- GAAP operating margin: 19.4% (vs 17.8% Q2)
- FCF margin: 22% — sixth consecutive positive quarter
- Magic Number: 0.51 (vs 0.78 trailing 4Q)

**Commentary:** Margin expansion is real but driven 60% by S&M underspend ($3.2M unspent vs plan) rather than structural leverage. Lumen Telemetry contributed $1.4M of the $4.1M ...

**DOC 2: DOC 2 — Pipeline Review Deck (CRO, Week 2 Oct)** (838c)

**Q4 Pipeline Snapshot — CRO to ELT**

- Q4 quota: $6.8M new ARR
- Stage 3+ pipeline coverage: 2.6x (healthy threshold 3.5x)
- Avg deal cycle: 94 days (up from 71 days in Q1)
- Win rate on competitive deals: 38% (vs 47% H1)
- Top loss reasons: 'Datadog bundle pricing' (31%), 'budget freeze' (24%), 'consolidation onto incumbent' (19%)

**CRO note:** 'We have 14 deals >$200K ACV slipping from Q4 to Q1 — most are not lost, they're stuck in procurement. I would not commit above $5.2M for Q4 internally. Lumen cross-sell motion is not yet productive; reps are confused about the combined SKU and we w...


---

### h3-F5-p1_founder_ceo-stage_a_series_b_growth_burning-001
docs=7 total_chars=6715

**DOC 1: DOC 1 — Q3 Financial Summary & Runway Model** (846c)

**Q3 2024 Financial Snapshot** (prepared by VP Finance)

- ARR: $14.2M (up from $11.8M in Q1, +20% YTD)
- Net new ARR Q3: $0.9M (vs $1.4M Q2, $1.6M Q1) — decelerating
- Gross margin: 71% (target 78%)
- Monthly burn: $1.31M avg over Q3
- Cash on hand: $18.4M → ~14 months runway at current burn
- CAC payback: 22 months (up from 17 in Q1)
- Magic Number: 0.6 (down from 0.9)

**Scenarios modeled:**
- *Status quo*: Cash-out April 2026; would need bridge or Series C by Jan 2026
- *30% headcount freeze + marketing -40%*: Extends runway to 22 months, ARR growth slows to ~12%
- *Aggressive growth (hire...

**DOC 2: DOC 2 — Pipeline Review (VP Sales)** (880c)

**Q4 Pipeline Review — VP Sales**

Qualified pipeline: $8.2M (vs $11.4M same time last year, -28%)
Weighted pipeline: $2.9M against $3.5M Q4 quota
Win rate: 18% (down from 26% H1)
Avg deal size: $48K ACV (flat)
Avg sales cycle: 94 days (up from 71)

**Loss reasons (last 30 deals lost):**
- 'Chose CompetitorX' — 11 deals (37%)
- 'Budget freeze / deferred' — 9 deals (30%)
- 'Built internally' — 4 deals
- 'No decision' — 6 deals

**Commentary:** 'CompetitorX is showing up in nearly every enterprise deal now. They're undercutting us by 25-35% and their AI roadmap demos better even though our actua...


---


## ORIGINAL-SAMPLE (seed=99)

### h3-F2-p2_cfo-stage_a_series_b_growth_burning-001
docs=6 total_chars=5745

**DOC 1: DOC 1 — October P&L and Runway Model Snapshot** (862c)

**October 2024 Financial Summary**

- Monthly recurring revenue: $1.183M (ARR $14.2M, +18% YoY but decelerating from +34% in Q1)
- Gross margin: 71% (down from 74% Q2 — hosting costs up due to enterprise tier usage)
- October opex: $2.51M; net burn: $1.34M
- Cash on hand: $18.7M → 13.9 months runway at current burn

**Headcount cost breakdown:**
- R&D: $920K/mo (38 FTE)
- S&M: $740K/mo (24 FTE — 11 AEs, 6 SDRs, 4 marketing, 3 ops)
- G&A: $310K/mo
- CS: $290K/mo (9 FTE)

**CFO commentary:** Magic number trending at 0.6 (target 0.75+). Net new ARR per S&M dollar has degraded for three consecutiv...

**DOC 2: DOC 2 — Q4 Pipeline Review (VP Sales)** (947c)

**Pipeline summary as of Nov 4 — submitted by VP Sales**

- Q4 quota: $4.8M new ARR; current commit: $2.9M; best case: $4.1M
- Pipeline coverage: 2.8x (target 3.5x); top of funnel down 22% QoQ
- Average sales cycle stretched from 67 → 94 days over last two quarters
- Win rate vs. Flowstack (primary competitor): 38% (was 51% in H1)

**Asks from Sales:**
1. Approve 4 additional enterprise AE hires in Q1 ($560K fully-loaded annualized) — argues we are leaving deals on the table in manufacturing vertical
2. $400K incremental Q1 spend on field marketing / industry events
3. Pricing flexibility: aut...


---

### h3-F5-p1_founder_ceo-stage_b_post_profitable_consolidation-001
docs=7 total_chars=6526

**DOC 1: DOC 1 — Q3 P&L Summary & Operating Model** (846c)

**Q3 FY24 Financial Summary** (prepared by CFO)

- ARR: $62.1M (+24% YoY, vs. +41% YoY in Q3 FY23)
- Net New ARR: $4.2M (vs. $5.1M Q2, $6.8M Q3 FY23)
- Gross margin: 78% (stable)
- Operating margin: 18.4% (vs. 16.1% Q2)
- FCF: $11.2M; Cash on BS: $148M; Runway: 30+ mo at current burn
- Rule of 40: 42.4 (24% growth + 18.4% margin)
- S&M as % of revenue: 34% (down from 48% in FY22)
- R&D as % of revenue: 22% (down from 28% in FY22)

**CFO commentary:** "We've earned the right to choose. Margin expansion is real but mostly came from S&M discipline and a hiring freeze, not productivity gains. If w...

**DOC 2: DOC 2 — Pipeline & Sales Capacity Review** (889c)

**Q3 Pipeline Review** — VP Sales & RevOps Lead

- Total qualified pipeline: $84M (1.9x coverage of Q4 quota — historically need 3.0x)
- Enterprise segment ($250K+ ACV): pipeline up 18% QoQ, win rate 31%
- Mid-market ($25-100K ACV): pipeline DOWN 22% QoQ, win rate fell from 26% → 19%
- Avg sales cycle: enterprise 142 days (up from 118), mid-market 67 days (up from 51)
- Rep capacity: 64 quota-carrying AEs; 71% attainment YTD; 22% attrited in last 12 mo
- Only 47% of new AEs (hired in last 9 mo) have closed a deal

**VP Sales note:** "Mid-market is being eaten alive by Datable.io's freemium mot...


---

### h3-F3-p4_vp_finance-stage_a_series_b_growth_burning-001
docs=6 total_chars=4681

**DOC 1: DOC 1 — September P&L and Burn Summary** (694c)

**September 2024 Financials (prelim, pre-close)**

- ARR: $14.2M (up from $13.6M in Aug; +4.4% MoM)
- New ARR booked: $780K (plan: $1.05M; 74% attainment)
- Net New ARR: $610K after $170K gross churn
- GAAP Revenue: $1.18M
- Gross Margin: 71% (down from 74% in Q2 — infra costs from new AI features)
- OpEx: $2.51M
  - S&M: $1.18M (47% of OpEx)
  - R&D: $0.92M
  - G&A: $0.41M
- Net Burn: $1.34M
- Cash on hand: $18.7M → **~14 months runway at current burn**

CFO commentary: 'We are tracking 11% behind plan on net new ARR YTD. If Q4 misses by another 15%, we should reforecast FY25 down ~$2M and re...

**DOC 2: DOC 2 — Q4 Pipeline Review (VP Sales)** (694c)

**Pipeline Snapshot — Oct 1**

- Q4 Quota: $3.2M new ARR
- Qualified pipeline: $8.4M (2.6x coverage; healthy benchmark is 3.0x)
- Late-stage (Commit + Best Case): $2.1M
- Avg sales cycle: 94 days (up from 71 days in H1) — buyers citing budget scrutiny
- Win rate vs. ContractIQ (primary competitor): **38%, down from 51% in Q2**

VP Sales notes: 'We are losing competitive deals on AI feature depth, not price. ContractIQ shipped clause-level redlining in August; we are 4-6 months behind. I need 3 additional AEs in Q1 AND product needs to close the AI gap by Feb or we will see Q1/Q2 attainment fal...


---

### h3-F4-p3_coo-stage_b_post_profitable_consolidation-001
docs=6 total_chars=4958

**DOC 1: DOC 1 — Q2 P&L Snapshot vs. Plan** (775c)

**Meridian Q2 FY25 P&L (preliminary, finance close T-3)**

| Metric | Q2 Actual | Q2 Plan | YoY |
|---|---|---|---|
| ARR (exit) | $62.1M | $64.5M | +14% |
| New ARR | $4.2M | $5.8M | -22% |
| Net New ARR | $1.9M | $3.4M | -38% |
| GAAP Op Margin | 19.4% | 17.0% | +680bps |
| FCF Margin | 22.1% | 19.5% | +540bps |
| S&M as % rev | 31% | 35% | -700bps |

**CFO commentary:** Margin beat driven by (1) delayed AE hiring (12 of 18 reqs unfilled), (2) lower variable comp on missed quota, (3) TrackForge synergy capture ahead of plan ($1.1M annualized opex out vs. $0.8M target). Growth shortfall is th...

**DOC 2: DOC 2 — Pipeline & Sales Capacity Review (RevOps)** (809c)

**Pipeline Health — Week of June 24**

Qualified pipeline coverage for Q3: **2.4x** (target 3.5x). Coverage has degraded for 3 consecutive quarters (3.8x → 3.1x → 2.7x → 2.4x).

**Diagnosis from VP Sales + RevOps Director:**
- AE ramp time has stretched from 5.2 → 7.8 months over 12 months. New hires inheriting smaller territories post-acquisition reshuffling.
- 14 of 47 quota-carrying AEs are below 50% of plan YTD; 6 are PIP candidates.
- Top-of-funnel: MQLs -18% YoY despite flat marketing spend. SDR-sourced pipeline -31%.
- Win rates on competitive deals vs. Flowstate (primary competitor) dr...


---

### h3-F1-p3_coo-stage_a_series_b_growth_burning-001
docs=7 total_chars=5621

**DOC 1: DOC 1 — Q3 Financial Snapshot & Runway Model** (742c)

**Prepared by VP Finance — Oct 2**

- ARR: $14.2M (vs plan $15.8M, -10%)
- Net new ARR Q3: $1.1M (vs plan $2.0M)
- Gross margin: 71% (target 75%)
- Monthly burn: $1.32M (trending up from $1.15M in Q1)
- Cash on hand: $17.1M → ~13 months runway at current burn
- Headcount: 142 (up from 98 at Series B close)
- S&M as % of revenue: 78% (peer benchmark: 50-60%)
- Magic number: 0.42 (below 0.75 efficiency threshold)

**Commentary:** Burn has scaled faster than revenue. If we hit plan in Q4 ($2.4M net new ARR) we extend to ~14 months; if we miss by 25%, runway compresses to 10 months and we'd need t...

**DOC 2: DOC 2 — Sales Pipeline & Capacity Review** (762c)

**From VP Sales — Sept 28**

- Q4 pipeline: $8.4M qualified (3.5x coverage on $2.4M target)
- Win rate trending down: 24% (Q1) → 19% (Q3)
- Average sales cycle: 71 days → 94 days
- AE ramp: new hires from May cohort at 38% of quota (expected 65%)
- Current AE count: 18; productive AEs: 11
- Top competitive losses: 6 of last 10 to Competitor X (cited price + integrations)

**Ask:** Hire 8 additional AEs in Q4 + 2 sales engineers ($1.4M annualized cost) to hit FY plan. 'We are capacity-constrained on enterprise deals.'

**Counter-signal:** Existing AEs at 58% of expected productivity. Adding cap...


---

